Acumen Pharmaceuticals announced it will release topline results in November 2026 from its Phase 2 ALTITUDE-AD study testing sabirnetug (ACU193) for early Alzheimer's disease. The study involves 542 participants and evaluates efficacy and safety over 18 months. The company also plans an IND filing for a new brain delivery program candidate by mid-2027. With $78.6 million in cash as of September 2026, Acumen expects to fund operations into early 2027, advancing its novel Alzheimer's treatments targeting toxic amyloid beta oligomers.
Acumen Pharmaceuticals reported its third quarter 2026 financial results and business highlights. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 26, 2026 16:51 WIB: out of 150 priced US health-sector stocks, 75 rose and 29 fell today. Notable movers include Moderna (MRNA) at USD 187.00 with a 1-day change of -6.55% and a typical hold time on Pluang of 58 days, GeneDx Holdings Corp (WGS) at USD 59.00 with +5.08% change and a 20-day hold time, and BioNTech SE (BNTX) at USD 84.31 with -4.32% change and a 60-day hold time.
Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...
E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...
AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...
AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
